000 days 00 hours 00 minutes 00 seconds
Before the start of the
OCT. 25-29, 2021
In the aftermath of the biggest health crisis in recent history, the Galien Week of Innovation is back with an exceptional lineup of speakers who will boil-down return-on-experience and global data, share their vision for post-pandemic strategies and benchmarks, and debate burning issues in global human health.
Galien Forum 2021 Speakers
Stephane Bancel
CEO, Moderna
Albert Bourla
CEO, Pfizer
Robert Bradway
Chairman & CEO, Amgen
Giovanni Caforio
Chairman & CEO, Bristol Myers Squibb
Sue Desmond-Hellmann, MD, MPh
Prix Galien USA Committee Chair; Former Chief Executive Officer of the Bill & Melinda Gates Foundation
Mikael Dolsten
Chief Scientific Officer & President, WW Research, Development and Medical, Pfizer
Ken Frazier
CEO, Merck & Co.
Belen Garijo
Vice Chair of the Executive Board & Deputy CEO, Merck KGaA
Laurie Glimcher
President & CEO, Dana-Farber Cancer Institute;
Professor of Medicine, Harvard Medical School
Alex Gorsky
CEO, J&J
Sebastian Guth
President of Pharmaceuticals, Americas Region, Bayer U.S. LLC
Michelle McMurry-Heath, President & CEO, BIO
Joel Marcus
Executive Chairman & Founder, Alexandria Real Estate Equities, Inc./ Alexandria Venture Investments; Co-Founder, Alexandria Summit
Michel Pairet
Board of Managing Directors – Innovation, Boehringer Ingelheim
Michael Rosenblatt
Co-Chair Galien Forum;
Chief Medical Officer, Flagship Pioneering
Ramona Sequeira
President, US Business Unit & Global Portfolio Commercialization, Takeda Pharmaceuticals
Pascal Soriot
CEO, AstraZeneca
Michel Vounatsos
CEO, Biogen
Lynne Zydowsky
Chief Science Officer, Alexandria Real Estate Equities, Inc. & Alexandria Venture Investments; President & Co-Founder Alexandria Summit
2020 IN NUMBERS
75
PRODUCTS
61
COMPANIES
13
THERAPEUTIC AREAS
Nominees 2020
Galien Week of Innovation Oct. 26-30
MONDAY
TUESDAY
WEDNESDAY
FRIDAY
IN THE PROGRAM
Monday
MedTech Webinars
Oct. 26th
Tuesday
BioTech Webinars
Oct. 27th
11AM - 12PM ET
Where is the growing science and its link to disease leading us in terms of new treatments for patients with unresolved chronic conditions?
12PM - 1:15PM ET
Can the foundational biologic understandings now being brought to cancer care be leveraged to secure a targeted, more personalized approach to other conditions?
1:30PM - 2:45PM ET
Will progress in therapies that promise a genetic cure for devastating rare diseases lead to similar innovations in patient access to these high-cost, high-touch treatments?
Wednesday
Pharma Webinars
Oct. 28th
11AM - 12:15PM ET
The ability to claim larger health system productivity benefits from the introduction of chronic disease medicines looms in importance as these therapeutic segments become more crowded and competitive.
12:30PM - 1:45PM ET
What are the prospects – and limitations – behind the new approaches to cancer treatments from our increased knowledge of the underlying biology behind tumor growth and proliferation?
2:00PM - 3:00PM ET
Are there common links in advancing research on hematologic cancers and other rare diseases associated with uncontrolled vascular system inflammation, such as sickle cell anemia?
3:00PM - 4:00PM ET
Will the coronavirus pandemic finally lead to an upswing in R&D to tackle neglected areas like antibiotic resistance, zoonotic transmission of pathogens and a more globally-coordinated approach to infectious diseases overall?
Thursday
Oct. 29th
6:00 PM – 7:30 PM ET
Friday
Media Presentation
Oct. 30th
11AM - 2PM ET
Exchanges with leaders from each of the 6 winning products, an update the 2021 International Prix Galien and Africa Forum, and conclusions and insights from key Forum panels
Our Sponsors
MISSED A SESSION? WATCH IT HERE
